Medical devices, distributed by reps who already have the relationships.
Selling a medical device is a credentialing problem before it is a clinical one. Solara reps are pre-credentialed at hospital systems and ambulatory surgery centers across the country, carry portfolios that cover adjacent specialties, and walk into rooms where decision makers already know them.
The device-launch problem
Most manufacturers spend twelve to eighteen months standing up a sales team — recruiting, credentialing at hospital systems and ASCs, training on procedure workflow, building referring-physician relationships. Solara compresses that to thirty days because the network already has the relationships, the credentials, and the procedure knowledge.
What changes when medical devices runs on the Solara network.
Pre-credentialed at the IDNs that matter
Reps maintain active credentialing across multi-hospital systems, ambulatory surgery centers, and physician-owned facilities. Your device gets in the door without your team negotiating a vendor agreement.
Adjacent-specialty portfolios
Reps carry non-competing devices across the same call points. The reason your rep got a meeting on your device is the half-hour conversation they were already having about something else.
Adoption analytics, not activity reports
We track physician-level utilization — first case, second case, ramp, plateau, churn risk — so you see what's converting and what's stalling, in time to do something about it.
Specialties served by this category.
- ·Orthopedic surgery
- ·Pain management
- ·Cardiology and electrophysiology
- ·Vascular and interventional
- ·Plastic and reconstructive surgery
- ·Spine
Who Solara distributes for in this category.
- ·Procedure-based devices (single-use, capital, hybrid)
- ·Implantables and prostheses
- ·Energy-based and electromechanical devices
- ·Surgical instruments and disposables
What manufacturers ask before they pilot.
- What kinds of medical devices does Solara distribute?
- Procedure-based devices, capital and hybrid equipment, implantables, surgical instruments, and clinical durables. We focus on devices that require a credentialed rep present in the OR or office to support adoption — that's where our network model has the largest leverage.
- How quickly can a manufacturer launch with Solara?
- Pilot territories typically go live in under thirty days from agreement to first call. Because reps are already credentialed and trained on adjacent procedures, ramp time on a new device is measured in weeks, not quarters.
- How does Solara handle hospital and ASC credentialing?
- Solara's reps maintain active credentialing across hospital systems, ASCs, and physician-owned facilities. Manufacturers don't run vendor-credentialing workflows separately — credentialing is a network-level capability, kept current per facility's requirements.
- Can Solara reps support cases in the OR?
- Yes. Reps maintain procedure-side training appropriate to their specialty mix and provide case coverage where the device requires it. Procedure support is part of the standard launch package, not an upsell.
- Does Solara handle device returns, complaints, or post-market surveillance?
- Solara reps log post-market events through the platform and route complaints to the manufacturer's quality system. We are a distribution and field-force partner — manufacturer-of-record responsibilities (post-market surveillance, complaint handling, MDR reporting) remain with the manufacturer.
Pilot a medical devices territory in 30 days.
Book a working session — we’ll load your target sub-segment into Solara live, walk through territory coverage, and propose a pilot scope.